Last reviewed · How we verify

NCT04217031

Decision Variability Between Different Heart Teams for Complex Coronary Artery Diseases

Completed Last updated 17 August 2021
What this trial tests

trial testing No intervention in Coronary Artery Disease in 101 participants. Completed in 1 March 2021.

Timeline
3 January 2020
Primary endpoint
1 March 2021
1 March 2021

Quick facts

Lead sponsorChina National Center for Cardiovascular Diseases
StatusCompleted
Study typeOBSERVATIONAL
Enrollment101
Start date3 January 2020
Primary completion1 March 2021
Estimated completion1 March 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

China National Center for Cardiovascular Diseases — full company profile →

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purposes of this study are 1) to explore the variability of decisions between different heart teams in complex coronary artery disease; 2) to evaluate the reasons of the discrepancy in decision making.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other China National Center for Cardiovascular Diseases trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04217031.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing